BioAmber (BIOA) Tops Q1 EPS by 2c
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
BioAmber (NYSE: BIOA) reported Q1 EPS of ($0.25), $0.02 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $2.37 million.
For earnings history and earnings-related data on BioAmber (BIOA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Thermo Fisher Scientific (TMO) Tops Q3 EPS by 6c; Raises Outlook
- Raytheon (RTN) Tops Q3 EPS by 13c, Lifts Outlook but In-Line with Street
- Bemis (BMS) Reports In-Line Q3 EPS; Guides a Touch Below the Street
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!